AFC
TEVA icon

Ares Financial Consulting’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ares Financial Consulting’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18K Sell
153
-60
-28% -$2K ﹤0.01% 702
2026
Q1 		$6.44K Buy
+213
New +$6.85K 0.01% 638

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Ares Financial Consulting's TEVA Position: Q2 2026 in Review

Ares Financial Consulting reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 28% in Q2 2026, selling an estimated $2K and leaving 153 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Ares Financial Consulting first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.44K in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Ares Financial Consulting held 153 shares of Teva Pharmaceutical Industries Limited worth $5.18K as of Q2 2026.
  • Ares Financial Consulting sold 60 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $2K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #702 holding.
  • Ares Financial Consulting first reported a position in Teva Pharmaceutical Industries Limited in Q1 2026 and has held it in 2 quarters since.
  • Ares Financial Consulting's Teva Pharmaceutical Industries Limited position peaked at $6.44K in Q1 2026.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.